Detalhe da pesquisa
1.
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer.
N Engl J Med
; 389(22): 2063-2075, 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37861218
2.
Phase 2 trial of crizotinib in Japanese patients with advanced NSCLC harboring a MET gene alteration: a Co-MET study.
Int J Clin Oncol
; 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38758397
3.
Efficacy of gilteritinib in comparison with alectinib for the treatment of ALK-rearranged non-small cell lung cancer.
Cancer Sci
; 114(11): 4343-4354, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37715310
4.
Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non-small-cell lung cancer in KEYNOTE-407.
Cancer Sci
; 114(8): 3330-3341, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37183528
5.
Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer.
N Engl J Med
; 383(10): 944-957, 2020 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32877583
6.
Efficacy of Selpercatinib in RET Fusion-Positive Non-Small-Cell Lung Cancer.
N Engl J Med
; 383(9): 813-824, 2020 08 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32846060
7.
[Survival Mechanisms of Drug Tolerant Persister Cancer Cells against Targeted Anticancer Drugs].
Gan To Kagaku Ryoho
; 50(12): 1239-1245, 2023 Dec.
Artigo
em Japonês
| MEDLINE | ID: mdl-38247057
8.
Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket trial.
Lancet Oncol
; 23(10): 1261-1273, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36108661
9.
Identification of targetable kinases in idiopathic pulmonary fibrosis.
Respir Res
; 23(1): 20, 2022 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35130915
10.
COVID-19 Vaccine-Associated Lymphadenopathy Mimicking Regrowth of Axillary Lymph Node Metastasis of Lung Adenocarcinoma.
Acta Med Okayama
; 76(5): 593-596, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36352807
11.
[Efficacy and Safety Analysis of Selpercatinib in Patients with RET Fusion-Positive Non-Small Cell Lung Cancer-Results from the Japanese Subset of a Global Phase 1/2 Study].
Gan To Kagaku Ryoho
; 49(6): 669-675, 2022 Jun.
Artigo
em Japonês
| MEDLINE | ID: mdl-35799394
12.
Capmatinib in Japanese patients with MET exon 14 skipping-mutated or MET-amplified advanced NSCLC: GEOMETRY mono-1 study.
Cancer Sci
; 112(4): 1556-1566, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33506571
13.
VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene-driven non-small-cell lung cancers.
Cancer Sci
; 112(5): 1853-1864, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33410241
14.
A novel osimertinib-resistant human lung adenocarcinoma cell line harbouring mutant EGFR and activated IGF1R.
Jpn J Clin Oncol
; 51(6): 956-965, 2021 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33829270
15.
Survival of chemo-naïve patients with EGFR mutation-positive advanced non-small cell lung cancer after treatment with afatinib and bevacizumab: updates from the Okayama Lung Cancer Study Group Trial 1404.
Jpn J Clin Oncol
; 51(8): 1269-1276, 2021 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34115855
16.
Beneficial effect of erlotinib and trastuzumab emtansine combination in lung tumors harboring EGFR mutations.
Biochem Biophys Res Commun
; 532(3): 341-346, 2020 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32888648
17.
Influence of age on the efficacy of immune checkpoint inhibitors in advanced cancers: a systematic review and meta-analysis.
Acta Oncol
; 59(3): 249-256, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31782328
18.
Immune checkpoint inhibitor efficacy and safety in older non-small cell lung cancer patients.
Jpn J Clin Oncol
; 50(12): 1447-1453, 2020 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32869100
19.
Anaplastic Lymphoma Kinase Fusion: A Review of Therapeutic Drugs and Treatment Strategies.
Acta Med Okayama
; 74(5): 371-379, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33106692
20.
Chemoradiotherapy for locally advanced lung cancer patients with interstitial lung abnormalities.
Jpn J Clin Oncol
; 49(5): 458-464, 2019 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30793176